342 related articles for article (PubMed ID: 31573379)
1. Relationship of Cannabis Use Disorder and Irritable Bowel Syndrome (IBS): An Analysis of 6.8 Million Hospitalizations in the United States.
Patel RS; Goyal H; Satodiya R; Tankersley WE
Subst Use Misuse; 2020; 55(2):281-290. PubMed ID: 31573379
[No Abstract] [Full Text] [Related]
2. Higher odds of irritable bowel syndrome among hospitalized patients using cannabis: a propensity-matched analysis.
Adejumo AC; Ajayi TO; Adegbala OM; Bukong TN
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):756-765. PubMed ID: 30807448
[TBL] [Abstract][Full Text] [Related]
3. Hypertensive Crisis-Related Hospitalizations and Subsequent Major Adverse Cardiac Events in Young Adults with Cannabis Use Disorder: A Nationwide Analysis.
Desai R; Jain A; Sultan W; Gandhi Z; Raju AR; Varughese VJ; Jnaneswaran G; Agarwal C; Rizvi B; Mansuri Z; Gupta P; Kumar G; Sachdeva R
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295625
[TBL] [Abstract][Full Text] [Related]
4. Sex Differences in Cannabis Use Disorder Diagnosis Involved Hospitalizations in the United States.
Zhu H; Wu LT
J Addict Med; 2017; 11(5):357-367. PubMed ID: 28700366
[TBL] [Abstract][Full Text] [Related]
5. Trends in documented cannabis use disorder among hospitalized adult epilepsy patients in the United States.
Lekoubou A; Fox J; Bishu KG; Ovbiagele B
Epilepsy Res; 2020 Jul; 163():106341. PubMed ID: 32361206
[TBL] [Abstract][Full Text] [Related]
6. Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy.
Meinhofer A; Hinde JM; Keyes KM; Lugo-Candelas C
JAMA Psychiatry; 2022 Jan; 79(1):50-58. PubMed ID: 34730782
[TBL] [Abstract][Full Text] [Related]
7. Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders.
Reeves LE; Gaudiano BA; Metrik J; Guzman Holst C; Morena A; Sydnor VJ; Weinstock LM; Epstein-Lubow G
J Dual Diagn; 2018; 14(3):171-180. PubMed ID: 30265850
[TBL] [Abstract][Full Text] [Related]
8. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample.
Hayley AC; Stough C; Downey LA
Eur Neuropsychopharmacol; 2017 Aug; 27(8):732-743. PubMed ID: 28663122
[TBL] [Abstract][Full Text] [Related]
9. Cannabis Use Disorder and Epilepsy: A Cross-National Analysis of 657 072 Hospitalized Patients.
Patel RS; Mekala HM; Tankersley WE
Am J Addict; 2019 Sep; 28(5):353-360. PubMed ID: 31124592
[TBL] [Abstract][Full Text] [Related]
10. Risk of Psychiatric Disorders following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study.
Lee YT; Hu LY; Shen CC; Huang MW; Tsai SJ; Yang AC; Hu CK; Perng CL; Huang YS; Hung JH
PLoS One; 2015; 10(7):e0133283. PubMed ID: 26222511
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States.
Wu LT; Zhu H; Mannelli P; Swartz MS
Drug Alcohol Depend; 2017 Aug; 177():153-162. PubMed ID: 28599214
[TBL] [Abstract][Full Text] [Related]
12. Cannabis use disorder among atrial fibrillation admissions, 2008-2018.
Chouairi F; Miller PE; Guha A; Clarke JR; Reinhardt SW; Ahmad T; Freeman JV; Desai NR; Friedman DJ
Pacing Clin Electrophysiol; 2021 Nov; 44(11):1934-1938. PubMed ID: 34506639
[TBL] [Abstract][Full Text] [Related]
13. Nondisordered Cannabis Use Among US Adolescents.
Sultan RS; Zhang AW; Olfson M; Kwizera MH; Levin FR
JAMA Netw Open; 2023 May; 6(5):e2311294. PubMed ID: 37133862
[TBL] [Abstract][Full Text] [Related]
14. Cannabis Use is an Independent Risk Factor for Manic Episode: A Report from 380,265 Bipolar Inpatients.
Patel RS; Cheema Z; Singla A; Cornejo M; Verma G
Subst Use Misuse; 2022; 57(3):344-349. PubMed ID: 34895014
[TBL] [Abstract][Full Text] [Related]
15. Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.
Padwa H; Huang D; Mooney L; Grella CE; Urada D; Bell DS; Bass B; Boustead AE
Subst Abuse Treat Prev Policy; 2022 May; 17(1):36. PubMed ID: 35527269
[TBL] [Abstract][Full Text] [Related]
16. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults.
Leadbeater BJ; Ames ME; Linden-Carmichael AN
Addiction; 2019 Feb; 114(2):278-293. PubMed ID: 30276906
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and impact of cannabis use disorder on acute ischemic stroke and subsequent mortality in elderly peripheral vascular disease patients: A population-based analysis in the USA (2016 - 2019).
Desai R; Brereton B; Patta HVC; Bansal P; Jain A; Vyas A
Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102162. PubMed ID: 37871709
[TBL] [Abstract][Full Text] [Related]
18. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome.
Zamani M; Alizadeh-Tabari S; Zamani V
Aliment Pharmacol Ther; 2019 Jul; 50(2):132-143. PubMed ID: 31157418
[TBL] [Abstract][Full Text] [Related]
19. Cannabis use disorder and increased risk of arrhythmia-related hospitalization in young adults.
Patel RS; Gonzalez MD; Ajibawo T; Baweja R
Am J Addict; 2021 Nov; 30(6):578-584. PubMed ID: 34432919
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems.
Lapham GT; Campbell CI; Yarborough BJH; Hechter RC; Ahmedani BK; Haller IV; Kline-Simon AH; Satre DD; Loree AM; Weisner C; Binswanger IA
Subst Abus; 2019; 40(3):268-277. PubMed ID: 30657438
[No Abstract] [Full Text] [Related]
[Next] [New Search]
